Evidence map›Paper›PMID 30946645›Full record

ArticleMicrobial genomics2019

EvoMining reveals the origin and fate of natural product biosynthetic enzymes.

Nelly Sélem-Mojica, César Aguilar, Karina Gutiérrez-García, Christian E Martínez-Guerrero, Fancisco Barona-Gómez

Abstract read
In one paragraph

Article in Microbial genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nelly Sélem-MojicaEvolution of Metabolic Diversity Laboratory, Langebio, Cinvestav-IPN, Irapuato, México.
César AguilarEvolution of Metabolic Diversity Laboratory, Langebio, Cinvestav-IPN, Irapuato, México.
Karina Gutiérrez-GarcíaEvolution of Metabolic Diversity Laboratory, Langebio, Cinvestav-IPN, Irapuato, México.
Christian E Martínez-GuerreroEvolution of Metabolic Diversity Laboratory, Langebio, Cinvestav-IPN, Irapuato, México.
Fancisco Barona-GómezEvolution of Metabolic Diversity Laboratory, Langebio, Cinvestav-IPN, Irapuato, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products (NPs), or specialized metabolites, are important for medicine and agriculture alike, and for the fitness of the organisms that produce them. NP genome-mining aims at extracting biosynthetic information from the genomes of microbes presumed to produce these compounds. Typically, canonical enzyme sequences from known biosynthetic systems are identified after sequence similarity searches. Despite this being an efficient process, the likelihood of identifying truly novel systems by this approach is low. To overcome this limitation, we previously introduced EvoMining, a genome-mining approach that incorporates evolutionary principles. Here, we release and use our latest EvoMining version, which includes novel visualization features and customizable databases, to analyse 42 central metabolic enzyme families (EFs) conserved throughout Actinobacteria, Cyanobacteria,

Indexed as

Evolution, MolecularSoftwareAcetolactate SynthaseActinobacteriaBacterial ProteinsCyanobacteriaGlutamate DehydrogenaseIndolesPhenolsPseudomonasSequence Analysis, DNAAcetolactate SynthaseBacterial ProteinsGlutamate DehydrogenaseIndolesPhenolsscytoneminevolutionary genomicsEvoMininggenome mining of natural productsscytonemin biosynthesisspecialized metabolism

Identifiers

PMID30946645
PMCPMC6939163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.